Heart and Vessels

, Volume 32, Issue 12, pp 1469–1477 | Cite as

Epidemiological and outcome data in Japanese patients with deep vein thrombosis with and without malignancy

  • Kensuke Yokoi
  • Masahiko Hara
  • Yasunori Ueda
  • Keiichi Yamamoto
  • Keiko Ota
  • Daijiro Kabata
  • Tetsuhisa Kitamura
  • Yasushi Sakata
  • Ayumi Shintani
Original Article
  • 254 Downloads

Abstract

There are very few epidemiological studies on Japanese patients with deep vein thrombosis (DVT). In particular, mortality rate differences in Japanese DVT patients with and without malignancy have rarely been evaluated. To elucidate these differences, we enrolled 211 patients who had been diagnosed with de-novo acute DVT of the pelvis or lower extremities between January 2012 and December 2015. The clinical characteristics, treatment information, and follow-up data were retrospectively assessed. We compared these variables in patients with (n = 120) and without (n = 91) concomitant malignancies. The median age of patients was 67 years, 33.7% were male, and 82.9% patients were treated with oral anticoagulants including direct oral anticoagulants. The clinical characteristics and treatment provided were almost identical in the two groups with some exceptions. Three-year survival rates of the total population, patients with malignancy, and patients without malignancy were 80.6, 67.6, and 97.6%, respectively (log-rank p < 0.001). Multivariable Cox regression analysis demonstrated that malignancy was independently associated with high risk of 3-year all-cause mortality with an adjusted hazard ratio of 9.1 (95% confidence interval; 2.1–39.0, p = 0.003). Bootstrap validation demonstrated an acceptable index corrected slope of 0.766 without significant overfitting in a multivariable model. In conclusion, we analyzed epidemiological data on Japanese patients with DVT. Malignancy was independently associated with increased 3-year all-cause mortality.

Keywords

Deep venous thrombosis Epidemiological data Malignancy Mortality 

Notes

Acknowledgements

We would like to express our heartfelt gratitude to the Japan Society of Clinical Research (http://www.japanscr.org/) for their dedicated support.

Compliance with ethical standards

All procedures performed in the study involving human participants were in accordance with the ethical standards of each institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Garcia DA, Baglin TP, Weitz JI, Samama MM, American College of Chest Physicians (2012) Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e24S–e43SCrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–3069CrossRefPubMedGoogle Scholar
  3. 3.
    Piazza G, Goldhaber SZ (2006) Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation 114:e28–e32CrossRefPubMedGoogle Scholar
  4. 4.
    May R, Thurner J (1957) The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 8:419–427CrossRefPubMedGoogle Scholar
  5. 5.
    Kumasaka N, Sakuma M, Shirato K (1999) Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 63:439–441CrossRefPubMedGoogle Scholar
  6. 6.
    JCS Joint Working Group (2011) Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). Circ J 75:1258–1281CrossRefGoogle Scholar
  7. 7.
    Keller K, Beule J, Coldewey M, Dippold W, Balzer JO (2015) Impact of advanced age on the severity of normotensive pulmonary embolism. Heart Vessels 30:647–656CrossRefPubMedGoogle Scholar
  8. 8.
    Itani R, Minami Y, Haruki S, Watanabe E, Hagiwara N (2017) Prognostic impact of disseminated intravascular coagulation score in acute heart failure patients referred to a cardiac intensive care unit: a retrospective cohort study. Heart Vessels. doi:10.1007/s00380-017-0946-y PubMedGoogle Scholar
  9. 9.
    Sakuma M, Nakamura M, Yamada N, Ota S, Shirato K, Nakano T, Ito M, Kobayashi T (2009) Venous thromboembolism: deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. Circ J 73:305–309CrossRefPubMedGoogle Scholar
  10. 10.
    Yamada N, Hanzawa K, Ota S, Nakamura M, Sato K, Ikura M, Suzuki T, Kaise T, Nakajima H, Ito M (2015) Occurrence of deep vein thrombosis among hospitalized non-surgical Japanese patients. Ann Vasc Dis 8:203–209CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Nakamura M, Miyata T, Ozeki Y, Takayama M, Komori K, Yamada N, Origasa H, Satokawa H, Maeda H, Tanabe N, Unno N, Shibuya T, Tanemoto K, Kondo K, Kojima T (2014) Current venous thromboembolism management and outcomes in Japan. Circ J 78:708–717CrossRefPubMedGoogle Scholar
  12. 12.
    Yamashita Y, Unoki T, Takagi D, Hamatani Y, Ishii M, Iguchi M, Ogawa H, Masunaga N, Wada H, Hasegawa K, Abe M, Akao M (2016) Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients. Heart Vessels 31:1084–1090CrossRefPubMedGoogle Scholar
  13. 13.
    Kucher N (2011) Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 364:861–869CrossRefPubMedGoogle Scholar
  14. 14.
    Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151:933–938CrossRefPubMedGoogle Scholar
  15. 15.
    Beyth RJ, Cohen AM, Landefeld CS (1995) Long-term outcomes of deep-vein thrombosis. Arch Intern Med 155:1031–1037CrossRefPubMedGoogle Scholar
  16. 16.
    Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 349:759–762CrossRefPubMedGoogle Scholar
  17. 17.
    Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699CrossRefPubMedGoogle Scholar
  18. 18.
    Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122:1712–1723CrossRefPubMedGoogle Scholar
  19. 19.
    Elyamany G, Alzahrani AM, Bukhary E (2014) Cancer-associated thrombosis: an overview. Clin Med Insights Oncol 8:129–137CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ 3rd (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162:1245–1248CrossRefPubMedGoogle Scholar
  21. 21.
    Lee AYY (2005) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. Br J Haematol 128:291–302CrossRefPubMedGoogle Scholar
  22. 22.
    Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850CrossRefPubMedGoogle Scholar
  23. 23.
    Spencer FA, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker RC, Goldberg RJ (2006) The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 21:722–727CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychanski R, Solymoss S, Routhier N, Douketis J, Danovitch K, Lee AY, Le Gal G, Wells PS, Corsi DJ, Ramsay T, Coyle D, Chagnon I, Kassam Z, Tao H, Rodger MA, Investigators SOME (2015) Screening for occult cancer in unprovoked venous thromboembolism. N Engl J Med 373:697–704CrossRefPubMedGoogle Scholar
  25. 25.
    Prandoni P, Bernardi E, Valle FD, Visonà A, Tropeano PF, Bova C, Bucherini E, Islam MS, Piccioli A (2016) Extensive computed tomography versus limited screening for detection of occult cancer in unprovoked venous thromboembolism: A. multicenter, controlled, randomized clinical trial. Semin Thromb Hemost 42:884–890CrossRefPubMedGoogle Scholar
  26. 26.
    Van Doormaal FF, Terpstra W, Van Der Griend R, Prins MH, Nijziel MR, Van De Ree MA, Büller HR, Dutilh JC, ten Cate-Hoek A, Van Den Heiligenberg SM, Van Der Meer J, Otten JM (2011) Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 9:79–84CrossRefPubMedGoogle Scholar
  27. 27.
    Galanaud J-P, Sevestre-Pietri MA, Bosson JL, Laroche JP, Righini M, Brisot D, Boge G, van Kien AK, Gattolliat O, Bettarel-Binon C, Gris JC, Genty C, Quere I; OPTIMEeV-SFMV Investigators (2009) Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 102:493–500PubMedGoogle Scholar
  28. 28.
    Gillet J-L, Perrin MR, Allaert FA (2007) Short-term and mid-term outcome of isolated symptomatic muscular calf vein thrombosis. J Vasc Surg 46:513–519CrossRefPubMedGoogle Scholar
  29. 29.
    Macdonald PS, Kahn SR, Miller N, Obrand D (2003) Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 37:523–527CrossRefPubMedGoogle Scholar
  30. 30.
    Tagaya M, Yoshikawa D, Sugishita Y, Yamauchi F, Ito T, Kamada T, Yoshinaga M, Mukaide D, Fujiwara W, Yokoi H, Hayashi M, Watanabe E, Ishii J, Ozaki Y, Izawa H (2016) Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution. Heart Vessels 31:957–962CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan KK 2017

Authors and Affiliations

  • Kensuke Yokoi
    • 1
  • Masahiko Hara
    • 2
  • Yasunori Ueda
    • 1
  • Keiichi Yamamoto
    • 3
  • Keiko Ota
    • 3
  • Daijiro Kabata
    • 2
  • Tetsuhisa Kitamura
    • 4
  • Yasushi Sakata
    • 5
  • Ayumi Shintani
    • 2
  1. 1.Cardiovascular DivisionOsaka National HospitalOsakaJapan
  2. 2.Department of Clinical Epidemiology and BiostatisticsOsaka University Graduate School of Medicine, Center of Medical Innovation and Translational Research 603ASuitaJapan
  3. 3.REDCap Group, Department of Medical InnovationOsaka University HospitalSuitaJapan
  4. 4.Division of Environmental Medicine and Population Sciences, Department of Social and Environmental MedicineOsaka University Graduate School of MedicineSuitaJapan
  5. 5.Department of Cardiovascular MedicineOsaka University Graduate School of MedicineSuitaJapan

Personalised recommendations